Treace Medical Concepts (TMCI) Capital Expenditures (2020 - 2026)
Treace Medical Concepts (TMCI) posted Capital Expenditures of $293000.0 for Q1 2026, down 97.78% on a QoQ basis from $13.2 million in Q4 2025, and down 91.73% year-over-year from $3.5 million in Q1 2025.
Treace Medical Concepts (TMCI) Capital Expenditures (2020 - 2026) Analysis & Trends
Treace Medical Concepts' Capital Expenditures history runs 7 years deep, the most recent figure standing at $293000.0 for Q1 2026.
- Quarterly Capital Expenditures fell 91.73% year-over-year to $293000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.3 million (up 165.09% YoY) and the FY2025 annual result came in at $13.5 million, up 3996.06% from the prior year.
- Capital Expenditures was $293000.0 for Q1 2026 at Treace Medical Concepts, down from $13.2 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $15.0 million in Q4 2022 and bottomed at -$6.8 million in Q3 2022.
- A 5-year average of $2.7 million and a median of $1.5 million in 2023 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2022 — Capital Expenditures sank 684.64% — and 2025, when it surged 73311.11%.
- Treace Medical Concepts' Capital Expenditures stood at $15.0 million in 2022, then slipped by 23.53% to $11.5 million in 2023, then sank by 99.84% to $18000.0 in 2024, then jumped by 73311.11% to $13.2 million in 2025, then plunged by 97.78% to $293000.0 in 2026.
- Business Quant data shows TMCI's Capital Expenditures at $293000.0 in Q1 2026, $13.2 million in Q4 2025, and -$62000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Treace Medical Concepts | 261.60 Mn | 209.75 Mn | 37.41 Mn | 293,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 293,000.00 |
| Mar 31, 2026 | 293,000.00 |
| Dec 31, 2025 | 13.21 Mn |
| Dec 31, 2025 | 13.21 Mn |
| Sep 30, 2025 | -62,000.00 |
| Sep 30, 2025 | -62,000.00 |
| Jun 30, 2025 | -3.18 Mn |
| Jun 30, 2025 | -3.18 Mn |
| Mar 31, 2025 | 3.54 Mn |
| Mar 31, 2025 | 3.54 Mn |
| Dec 31, 2024 | 18,000.00 |
| Dec 31, 2024 | 18,000.00 |
| Sep 30, 2024 | 312,000.00 |
| Sep 30, 2024 | 312,000.00 |
| Dec 31, 2023 | 11.46 Mn |
| Dec 31, 2023 | 11.46 Mn |
| Sep 30, 2023 | -5.71 Mn |
| Sep 30, 2023 | -5.71 Mn |
| Jun 30, 2023 | 4.23 Mn |
| Jun 30, 2023 | 4.23 Mn |